Rather, 197 single nucleotide variations in a preponderance of cancer-related genes were identified; 33% of small intestinal NET patients showed PIK3/Akt/mTOR pathway alteration, and 72% had therapeutically actionable genomic alterations [13]. This evidence concerns the gene PIK3CG and cancer.